— Know what they know.
Not Investment Advice

SERA NASDAQ

Sera Prognostics, Inc.
1W: +1.5% 1M: +3.0% 3M: -1.0% YTD: -31.0% 1Y: -29.8% 3Y: +10.7% 5Y: -79.6%
$2.09
+0.05 (+2.45%)
 
Weekly Expected Move ±4.5%
$2 $2 $2 $2 $2
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 40 · $79.8M mcap · 27M float · 0.126% daily turnover · Short 39% of daily vol

Income Trends

Revenue
$81K +5.2% ▲
5Y CAGR: +26.5%
Gross Profit
-$83K -1560.0% ▼
Operating Income
-$37M +0.4% ▲
Net Income
-$32M +2.9% ▲
EPS (Diluted)
$-0.67 +32.3% ▲
EBITDA
-$36M -11.0% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$82K$268K$306K$77K$81K
YoY Growth+228.0%+226.8%+14.2%-74.8%+5.2%
Cost of Revenue$37K$193K$210K$82K$164K
Gross Profit$45K$75K$96K-$5K-$83K
Gross Margin54.9%28.0%31.4%-6.5%-102.5%
R&D Expenses$11M$14M$15M$15M$13M
SG&A Expenses$24M$31M$25M$22M$23M
Operating Expenses$35M$46M$40M$37M$36M
Operating Income-$35M-$46M-$40M-$37M-$37M
Operating Margin-43164.6%-17034.3%-13013.4%-47577.9%-45066.7%
Interest Expense$746K$61K$55K$28K$9K
Income Before Tax-$35M-$44M-$36M-$33M-$32M
Tax Expense$0$0$0$0$0
Net Income-$35M-$44M-$36M-$33M-$32M
Net Margin-42693.9%-16487.3%-11843.8%-42724.7%-39417.3%
EPS (Diluted)$-1.18$-1.43$-1.16$-0.99$-0.67
EBITDA-$34M-$43M-$35M-$32M-$36M
Shares Outstanding31M31M31M33M48M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms